b Tested in sodium chloride 0.9%.
c Tested in sodium chloride 0.45%.
d Tested in dextrose 5%, Ringer’s injection, lactated, sodium chloride 0.45%, and sodium chloride 0.9%.
e Tested in both dextrose 5% and sodium chloride 0.9%.
f Tested in bacteriostatic sodium chloride 0.9% preserved with benzyl alcohol 0.9%.
g Tested in dextrose 5%, Ringer’s injection, lactated, and sodium chloride 0.9%.
h Tested in sterile water for injection.
i Tested in dextrose 5% with sodium bicarbonate 0.05 mEq/mL.
j Lyophilized formulation tested.
k Refer to Appendix for the composition of the parenteral nutrition solutions. TNA indicates a 3-in-1 admixture, and TPN indicates a 2-in-1 admixture.
l Test performed using the formulation WITHOUT edetate disodium.
m Tested in combination with hydrocortisone sodium succinate (Upjohn) 100 mg/L.
n Tested in combination with heparin sodium (Riker) 1000 units/L.
o Piperacillin component. Piperacillin in an 8:1 fixed-ratio concentration with tazobactam.
p Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.
q Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.
r Test performed using the formulation WITH edetate disodium.
s Imipenem component. Imipenem in a 2:2:1 fixed-ratio concentration with cilastatin and relebactam.
t Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.